These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26555587)

  • 1. Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
    Montes JA; Johnson D; Jorgensen J; McElmeel ML; Fulcher LC; Kiel JW
    Cornea; 2016 Jan; 35(1):122-6. PubMed ID: 26555587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro potency and stability of fortified ophthalmic antibiotics.
    Arici MK; Sümer Z; Güler C; Elibol O; Saygi G; Cetinkaya S
    Aust N Z J Ophthalmol; 1999 Dec; 27(6):426-30. PubMed ID: 10641902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term potency, sterility, and stability of vancomycin, ceftazidime, and moxifloxacin for treatment of bacterial endophthalmitis.
    Mehta S; Armstrong BK; Kim SJ; Toma H; West JN; Yin H; Lu P; Wayman LL; Recchia FM; Sternberg P
    Retina; 2011; 31(7):1316-22. PubMed ID: 21358364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of self-prepared fortified antibiotic eyedrops.
    Lin CP; Tsai MC; Sun CY; Chen JY; Lin SR
    Kaohsiung J Med Sci; 1999 Feb; 15(2):80-6. PubMed ID: 10089717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations.
    Bowe BE; Snyder JW; Eiferman RA
    Am J Ophthalmol; 1991 Jun; 111(6):686-9. PubMed ID: 1903903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
    Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
    Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stability of fortified ophthalmic antibiotics stored at -20 degrees C for 6 months.
    Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
    Cornea; 2010 Jul; 29(7):807-11. PubMed ID: 20489598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterility of non-preservative eye drops.
    Prabhasawat P; Chotikavanich S; Leelaporn A
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S6-10. PubMed ID: 16681044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fortified antibiotic (vancomycin, amikacin and ceftazidime) eye drop stability assessment at -20 degrees C].
    Chédru-Legros V; Fines-Guyon M; Chérel A; Perdriel A; Albessard F; Debruyne D; Mouriaux F
    J Fr Ophtalmol; 2007 Oct; 30(8):807-13. PubMed ID: 17978677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fixed combination of fortified vancomycin and amikacin ophthalmic solution--VA solution: in vitro study of the potency and stability.
    Lin JM; Tsai YY; Fu YL
    Cornea; 2005 Aug; 24(6):717-21. PubMed ID: 16015092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Vancomycin Drops Reduce the Severity of Early Bacterial Keratitis in Keratoprosthesis.
    Konstantopoulos A; Tan XW; Goh GT; Saraswathi P; Chen L; Nyein CL; Zhou L; Beuerman R; Tan DT; Mehta JS
    PLoS One; 2015; 10(10):e0139653. PubMed ID: 26460791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability and Sterility of Extemporaneously Prepared Nonpreserved Cefazolin, Ceftazidime, Vancomycin, Amphotericin B, and Methylprednisolone Eye Drops.
    Ratprasatporn N; Wittayalertpanya S; Khemsri W; Chatsuwan T; Chongpison Y; Chamsai T; Wattanakijkarn M; Chansangpetch S
    Cornea; 2019 Aug; 38(8):1017-1022. PubMed ID: 31090593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.
    Rojanarata T; Tankul J; Woranaipinich C; Potawanich P; Plianwong S; Sakulma S; Saehuan C
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):485-90. PubMed ID: 20879806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
    Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
    Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
    Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
    Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates.
    Harper T; Miller D; Flynn HW
    Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of gentamicin sulfate and tobramycin sulfate in extemporaneously prepared ophthalmic solutions at 8 degrees C.
    McBride HA; Martinez DR; Trang JM; Lander RD; Helms HA
    Am J Hosp Pharm; 1991 Mar; 48(3):507-9. PubMed ID: 2028997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.